文献速递泌尿与男性生殖病理细胞病理与分子病理

Lund分类系统:从基因表达聚类到癌细胞分子表型

The Lund taxonomy for bladder cancer classification - from gene expression clustering to cancer cell molecular phenotypes, and back again.
PubMed 文献 · J Pathol · 2023-02-17

本文综述了Lund分类系统(LundTax)的建立逻辑与步骤,旨在将膀胱癌基因表达水平分类与免疫组化分类对齐,识别独立于浸润和增殖的癌细胞表型。该系统独立于病理分期,适用于所有尿路上皮癌,有助于统一分子生物学家与病理学家的分类实践。

要点

  • LundTax通过基因表达聚类与仅由癌细胞表达标志物的免疫组化验证,定义癌细胞分子表型。
  • 该分类独立于病理分期,适用于所有尿路上皮癌。
  • 统一分类有助于系统化当前治疗实践并促进新疗法开发。

核心结论

  • LundTax将基因表达水平分类与免疫组化分类协调一致,识别独立于浸润和增殖的癌细胞表型。

研究设计与样本

  • 本文为综述,系统描述LundTax的发展步骤,包括基因表达聚类经免疫组化验证与调整。

主要发现

  • 基因表达聚类经仅由癌细胞表达标志物的免疫组化验证和调整,使分子亚型与癌细胞水平所见对应。
  • LundTax独立于病理分期,适用于所有尿路上皮癌。

临床怎么用

  • 统一分类系统可促进当前治疗实践的系统化,并支持新治疗方法的开发。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Treatment of bladder cancer patients depends on precise diagnosis. Molecular subtyping by gene expression profiling may contribute substantially to subclassification of bladder cancer. Several classification systems have been proposed. Most of these base their classification on whole biopsy features, and molecular subtypes are therefore often defined by a combination of features from the cancer cells as well as infiltrating noncancer cells. This makes the link to what is seen at the cancer cell level unclear. The aim of the Lund taxonomy (LundTax) has been to align gene expression-level classification with immunohistochemical classification to identify cancer cell phenotypes independent of infiltration and proliferation. A systematic approach was used in which gene expression clusters were validated and adjusted by immunohistochemistry using markers expressed only by the cancer cells. This review provides a rationale for defining molecular subtypes and a step-by-step description of the development of the LundTax with motivations for each modification and extension. As the cancer cell phenotype defined by gene expression profiling corresponds with the immunohistochemistry of cancer cells, the LundTax represents a harmonization of the gene expression and immunohistochemical levels. Furthermore, the classification system is independent of pathological stage and is, thus, applicable to all urothelial carcinomas. A unified classification system relevant for both the molecular biologist and pathologist will facilitate systematization of current treatment practices, as well as the development of new treatments. © 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

来源:J Pathol,查看原文。版权归原作者所有。

引用

  1. Höglund M, Bernardo C, Sjödahl G, et al. The Lund taxonomy for bladder cancer classification - from gene expression clustering to cancer cell molecular phenotypes, and back again. J Pathol. 2023. PMID: 36700594. doi:10.1002/path.6062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。